 |
PDBsum entry 4tpt
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
4tpt
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase/transferase inhibitor
|
 |
|
Title:
|
 |
Crystal structure of the human limk2 kinase domain in complex with a non-atp competitive inhibitor
|
|
Structure:
|
 |
Lim domain kinase 2. Chain: a, b. Fragment: kinase domain (unp residues 330-632). Synonym: limk-2. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: limk2. Expressed in: unidentified baculovirus. Expression_system_taxid: 10469
|
|
Resolution:
|
 |
|
2.60Å
|
R-factor:
|
0.223
|
R-free:
|
0.274
|
|
|
Authors:
|
 |
N.C.Goodwin,G.Cianchetta,B.L.Hamman,H.A.Burgoon,J.Healy,S.Mabon, E.D.Strobel,S.Wang,D.B.Rawlins
|
|
Key ref:
|
 |
N.C.Goodwin
et al.
(2015).
Discovery of a Type III Inhibitor of LIM Kinase 2 That Binds in a DFG-Out Conformation.
Acs Med Chem Lett,
6,
53-57.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
09-Jun-14
|
Release date:
|
22-Oct-14
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P53671
(LIMK2_HUMAN) -
LIM domain kinase 2 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
638 a.a.
279 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.11.1
- non-specific serine/threonine protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Acs Med Chem Lett
6:53-57
(2015)
|
|
PubMed id:
|
|
|
|
|
| |
|
Discovery of a Type III Inhibitor of LIM Kinase 2 That Binds in a DFG-Out Conformation.
|
|
N.C.Goodwin,
G.Cianchetta,
H.A.Burgoon,
J.Healy,
R.Mabon,
E.D.Strobel,
J.Allen,
S.Wang,
B.D.Hamman,
D.B.Rawlins.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The first allosteric, type III inhibitor of LIM-kinase 2 (LIMK2) is reported. A
series of molecules that feature both an N-phenylsulfonamide and tertiary amide
were not only very potent at LIMK2 but also were extremely selective against a
panel of other kinases. Enzymatic kinetic studies showed these molecules to be
noncompetitive with ATP, suggesting allosteric inhibition. X-ray crystallography
confirmed that these sulfonamides are a rare example of a type III kinase
inhibitor that binds away from the highly conserved hinge region and instead
resides in the hydrophobic pocket formed in the DFG-out conformation of the
kinase, thus accounting for the high level of selectivity observed.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |